Thu, Dec 18, 2014, 12:05 PM EST - U.S. Markets close in 3 hrs 55 mins


% | $
Quotes you view appear here for quick access.

Keryx Biopharmaceuticals Inc. Message Board

  • going1green going1green Feb 14, 2013 8:55 AM Flag

    CELG Wins Full FDA Approval In China. // linked

    ARTICLE : Celgene Wins Chinese Approval for Revlimid (( LINK ))
    Motley Fool
    By Dan Carroll | More Articles | Save For Later
    February 13, 2013 | Comments (0)

    Biotech company Celgene (NASDAQ: CELG ) has announced that its subsidiary Celgene International Sàrl has won full regulatory approval from the China State Food and Drug Administration for Revlimid.

    Revlimid, used to treat relapsed or refractory multiple myeloma in patients who have already undergone at least one therapy, is expected to be available to Chinese patients sometime late in the second quarter. The drug, which is already approved in numerous other locations, recorded more than $3.7 billion in sales in 2012.

14.52+0.43(+3.05%)12:03 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.